Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 3 | 15↑517.5% | 8↓46.1% |
| Gross Profit | -0 | 0 | 0 | 15↑102913.5% | 8↓46.1% |
| Operating Income | -43 | -173↓302.9% | -126↑27.3% | -72↑42.5% | -91↓26.3% |
| Net Income | -43 | -175↓305.9% | -166↑4.9% | -112↑32.8% | -89↑20.0% |
| EBITDA | -60 | -173↓187.8% | -160↑7.5% | -105↑34.1% | -88↑16.4% |
| EPS Diluted | -3.40 | -4.64↓36.5% | -3.78↑18.5% | -0.96↑74.6% | -0.36↑62.8% |